160
Participants
Start Date
October 21, 2024
Primary Completion Date
October 1, 2025
Study Completion Date
October 1, 2026
ASA injection 40 mg group
Participants will receive intra-articular knee injections under ultrasound guidance with AMNIOGEN® 40mg (HCT Regenerative, New Taipei, Taiwan) diluted in 3.0 mL of sterile normal saline.
ASA injection 20 mg group
Participants will receive intra-articular knee injections under ultrasound guidance with AMNIOGEN® 20mg (HCT Regenerative, New Taipei, Taiwan) diluted in 3.0 mL of sterile normal saline.
HA injection group
Participants will receive intra-articular knee injections under ultrasound guidance with 3 ml of HyLink (SEIKAGAKU CORPORATION, Tokyo, Japan).
Normal saline injection group
Participants will receive intra-articular knee injections under ultrasound guidance with 3 ml of sterile normal saline.
RECRUITING
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung
RECRUITING
Department of Physical Medicine and Rehabilitation, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
Chang Gung Memorial Hospital
OTHER